Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Brade

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2014
Stereotactic body radiotherapy in patients with previous pneumonectomy: safety and efficacyRobert Thompson, Meredith Giuliani, Mei Ling Yap, et al.
Cancer|August 31, 2010
Utilization of prophylactic cranial irradiation in patients with limited stage small cell lung carcinomaMeredith Giuliani, Alexander Sun, Andrea Bezjak, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2017
Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular CarcinomaMichael Velec, Carol R Haddad, Tim Craig, et al.
Journal of Surgical Oncology|February 27, 2018
Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in CanadaBenjamin P T Loveday, Jennifer J Knox, Laura A Dawson, et al.
Investigational New Drugs|May 11, 2010
A dose-escalation phase I trial of nimotuzumab, an antibody against the epidermal growth factor receptor, in patients with advanced solid malignanciesBenoit You, Anthony Brade, Joao M Magalhaes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
Practical considerations arising from the implementation of lung stereotactic body radiation therapy (SBRT) at a comprehensive cancer centerMax Dahele, Shannon Pearson, Tom Purdie, et al.
The Oncologist|August 30, 2020
Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung CancerBarbara Melosky, Parneet K Cheema, Anthony Brade, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Phase II trial of palliative radiotherapy for hepatocellular carcinoma and liver metastasesHany Soliman, Jolie Ringash, Haiyan Jiang, et al.
Clinical Lung Cancer|July 7, 2011
Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapyMeredith E Giuliani, Soha Atallah, Alexander Sun, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II studyAnthony Brade, James Brierley, Amit Oza, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2014
Stereotactic body radiotherapy in patients with previous pneumonectomy: safety and efficacyRobert Thompson, Meredith Giuliani, Mei Ling Yap, et al.
Cancer|August 31, 2010
Utilization of prophylactic cranial irradiation in patients with limited stage small cell lung carcinomaMeredith Giuliani, Alexander Sun, Andrea Bezjak, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2017
Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular CarcinomaMichael Velec, Carol R Haddad, Tim Craig, et al.
Journal of Surgical Oncology|February 27, 2018
Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in CanadaBenjamin P T Loveday, Jennifer J Knox, Laura A Dawson, et al.
Investigational New Drugs|May 11, 2010
A dose-escalation phase I trial of nimotuzumab, an antibody against the epidermal growth factor receptor, in patients with advanced solid malignanciesBenoit You, Anthony Brade, Joao M Magalhaes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
Practical considerations arising from the implementation of lung stereotactic body radiation therapy (SBRT) at a comprehensive cancer centerMax Dahele, Shannon Pearson, Tom Purdie, et al.
The Oncologist|August 30, 2020
Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung CancerBarbara Melosky, Parneet K Cheema, Anthony Brade, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Phase II trial of palliative radiotherapy for hepatocellular carcinoma and liver metastasesHany Soliman, Jolie Ringash, Haiyan Jiang, et al.
Clinical Lung Cancer|July 7, 2011
Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapyMeredith E Giuliani, Soha Atallah, Alexander Sun, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II studyAnthony Brade, James Brierley, Amit Oza, et al.
Pageof 6